Are there published clinical study results for EMVITAL?
As of August 2026, there are no published numerical results from completed clinical trials specifically evaluating EMVITAL. The primary registered study remains ongoing, and no peer-reviewed efficacy data have been released.
What is the main clinical study on EMVITAL?
ClinicalTrials.gov Identifier NCT07661121 – EMVITAL + EMFACE Combination Therapy for Temporomandibular Joint (TMJ) Pain Relief. Sponsored by BTL Industries Ltd. Status: Active, not recruiting (last update June 22, 2026).
Have any results been published from this study?
No. As of August 2026, no results have been posted on ClinicalTrials.gov and no peer-reviewed publications reporting efficacy or safety outcomes from NCT07661121 are publicly available.
What is the most accurate way to describe the clinical evidence for EMVITAL right now?
EMVITAL is supported by official FDA-aligned indications, an active multi-center clinical trial (NCT07661121) evaluating combination use for TMJ pain (results not yet available), clinic-reported histological observations related to inflammation, and consistent real-world patient and provider feedback on comfort and temporary relief.